Esperoct

Novo Nordisk Patient Assistance Program (PAP) Patient Guide: How to Get Esperoct at Low or No Cost

Esperoct (turoctocog alfa pegol) is a prescription medicine used to treat and prevent bleeding episodes in adults and children with hemophilia A, a genetic bleeding disorder where blood does not clot properly.[2] The Novo Nordisk Patient Assistance Program (PAP) offers Esperoct free of charge to eligible patients who cannot afford their medication, with no registration fees or monthly costs.[1][5]

About Esperoct and Hemophilia A

Esperoct is an extended half-life factor VIII therapy designed for routine prophylaxis (regular treatment to prevent bleeds), on-demand treatment of bleeding episodes, and perioperative management (control of bleeding during surgery).[2] Unlike short-acting factor treatments, Esperoct's pegylation technology allows for fewer infusions per week, potentially improving quality of life for people with hemophilia A.[2] It is not indicated for von Willebrand disease.[2]

Hemophilia A affects about 1 in 5,000 male births and requires lifelong treatment to replace missing clotting factor VIII. Without proper management, spontaneous or injury-related bleeds can damage joints, muscles, and organs. Esperoct helps reduce bleeding frequency when used prophylactically.[2]

Who Qualifies for the Program?

The Novo Nordisk PAP is for uninsured or underinsured U.S. patients facing financial hardship. Key eligibility criteria include:[5]

• U.S. citizen or legal resident.
• No prescription coverage (e.g., no HMO, PPO, or other insurance that covers the medication).[5]
• Prescribed a Novo Nordisk hemophilia factor product like Esperoct for an indicated condition.[5]
• Household income at or below 400% of the Federal Poverty Level (FPL).[5]
• Not enrolled in government programs like Medicaid (unless denied) or Medicare LIS (Low-Income Subsidy).[3][5]

Medicare Part D patients no longer need to meet a $1,000 out-of-pocket spend threshold.[1] Patients eligible for Medicaid or Medicare LIS must submit a denial letter.[3]

Important 2026 Update: Some Novo Nordisk medicines are no longer covered by PAP. Confirm Esperoct eligibility by calling 1-844-668-6732 or checking the program list.[1]

Income Eligibility Breakdown

Eligibility is based on total household income compared to 400% FPL. Use the table below for 2026 guidelines (FPL adjusts annually; verify current levels via HHS.gov or program contact). These are approximate U.S. guidelines for the 48 contiguous states + DC.[5]

Add ~$21,440 per additional person. Alaska/Hawaii have higher limits. Income includes wages, Social Security, etc. Provide proof like tax returns or pay stubs.[5]

Insurance Requirements

Patients must not have prescription coverage through private insurance (HMO/PPO), employer plans, or government programs that cover Esperoct.[5] If insured, explore co-pay assistance or coverage gap programs via NovoCare at 1-844-668-6732 first.[2] Medicare patients qualify without prior spend-down, but LIS-eligible must apply for denial.[1][3] Do not bill insurance for free PAP product.[5]

Step-by-Step Application Process

1. Get Prescribed: Ask your doctor to prescribe Esperoct and complete Part 1 of the PAP application (prescriber signature and date required).[5][8]

2. Download Form: Get the Novo Nordisk Hemophilia PAP Application (Spanish available).[5] Or call 1-844-668-6732 for help.[2]

3. Complete Patient Section: Fill Part 3 (patient certification and signature). Opt for phone/text alerts if desired.[1][8]

4. Gather Documents: See required list below. Attach all.[5][8]

5. Submit: Mail or fax to address on form. Doctor may eRx to Neovance Specialty Pharmacy (NPI 1780811125).[3]

6. Wait for Approval: Processed in 2 business days if complete; delays for missing info.[1] Get letter, SMS, or automated call.[1][8]

Required Documents (not exhaustive; confirm with program):[5][8]

• Proof of income (tax return, W-2, pay stubs, SSA award letter).
• Proof of residency (ID, utility bill).
• Insurance denial letter (if applicable).
• Prescriber details and prescription.

Timeline and Delivery

• Processing: 2 business days (complete apps only).[1][8]
• Notification: Mail letter + optional phone/text.[1]
• Delivery: Call from Neovance Specialty Pharmacy at 1-800-488-5908 to schedule home shipment within 5 business days.[1][3] Or to doctor's office/HCP (up to 10-14 business days).[8]
• Refills: Annual re-enrollment; phone/text for coordination.[3]

Shipped free to your home or chosen address. Product availability may change.[1]

Alternatives if Denied or Ineligible

• Interim Product Program: Bridge during coverage gaps; call 1-844-668-6732.[2]
• Free Trial Prescription: Try Esperoct; contact NovoCare.[2][6]
• QuickCheck Benefits Verification: Find coverage options.[2]
• Co-Pay Savings: If insured, via NovoCare.[2]
• Other PAPs: Search RxAssist.org or NeedyMeds.org.
• State Programs: Check for hemophilia assistance.
• Biosimilars: None listed currently.[ ]

Reapply if circumstances change (e.g., job loss).[8]

Disclaimer

This guide is for informational purposes based on publicly available data as of 2026. Novo Nordisk reserves the right to modify or cancel the PAP without notice.[1] Eligibility, product availability, and guidelines can change. Always contact NovoCare at 1-844-668-6732 or visit NovoCare.com for latest details. Not legal/medical advice—consult your doctor. Do not resell or bill for free product.[5] Word count: 1028.